R848, a toll-like receptor 7 agonist, inhibits osteoclast differentiation but not survival or bone-resorbing function of mature osteoclasts

R848, also known as resiquimod, acts as a ligand for toll-like receptor 7 (TLR7) and activates immune cells. In this study, we examined the effects of R848 on differentiation, survival, and bone-resorbing function of osteoclasts. R848 inhibited osteoclast differentiation of mouse bone marrow-derived...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Miyamoto, Arei, Takami, Masamichi, Matsumoto, Akifumi, Mochizuki, Ayako, Yamada, Takako, Tachi, Keita, Shibuya, Isao, Nakamachi, Tomoya, Shioda, Seiji, Baba, Kazuyoshi, Inoue, Tomio, Miyamoto, Yoichi, Yim, Mijung, Kamijo, Ryutaro
Format: Artigo
Jezik:Inglês
Izdano: Springer Netherlands 2012
Teme:
JAACT Special Issue
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3386391/
https://ncbi.nlm.nih.gov/pubmed/22358541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-012-9442-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items